Results 251 to 260 of about 99,547,245 (298)
Some of the next articles are maybe not open access.

CTLA-4 AT-Repeat Polymorphism Reduces the Inhibitory Function of CTLA-4 in Graves' Disease

Thyroid, 2003
Graves' disease (GD) is thought to be an autoimmune disease with a strong genetic component. Candidate genes include human leukocyte antigen (HLA) class II genes and CTLA-4. The CTLA-4 gene has a variable length AT-repeat polymorphism in the 3'-untranslated region. We previously found that the AT-repeat of 104 bp or longer was associated with GD.
Masaki, Takara   +2 more
openaire   +2 more sources

CTLA-4 upregulation during aging

Mechanisms of Ageing and Development, 2002
The immune system gradually becomes anergic with age. Here, we measured intracellular levels of cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), a negative regulator of T-cells, in 53 healthy individuals aged 18-94.
Qibin, Leng, Zvi, Bentwich, Gadi, Borkow
openaire   +2 more sources

Treg and CTLA-4: Two Intertwining Pathways to Immune Tolerance [PDF]

open access: yesJournal of Autoimmunity, 2013
Both the CTLA-4 pathway and regulatory T cells (Treg) are essential for the control of immune homeostasis. Their therapeutic relevance is highlighted by the increasing use of anti-CTLA-4 antibody in tumor therapy and the development of Treg cell transfer
Lucy Walker
exaly   +2 more sources

A Native Soluble Form of CTLA-4

Cellular Immunology, 2000
CTLA-4 is an immunoregulatory receptor expressed on the surface of activated T and B lymphocytes. The counterreceptors for CTLA-4 are the B7 family molecules. We describe alternatively spliced mRNAs expressed in hematolymphoid tissues of humans, mice, and rats that lack the transmembrane domain coded by exon 3 of the CTLA-4 gene.
Oaks, Martin   +5 more
openaire   +2 more sources

CTLA-4 and T cell activation

Current Opinion in Immunology, 1999
The past year has seen significant advances in our understanding of the role of cytotoxic T lymphocyte antigen 4 (CTLA-4) in regulating T cell activation and tolerance. Recent studies indicate that CTLA-4 not only counterbalances CD28 signals but also can inhibit T cell responses independently of CD28. Recent work has also revealed a role for CTLA-4 in
M A, Oosterwegel   +4 more
openaire   +2 more sources

A MOLECULAR PERSPECTIVE OF CTLA-4 FUNCTION

Annual Review of Immunology, 2006
Within the paradigm of the two-signal model of lymphocyte activation, the interest in costimulation has witnessed a remarkable emergence in the past few years with the discovery of a large array of molecules that can serve this role, including some with an inhibitory function.
Teft, Wendy A.   +2 more
openaire   +2 more sources

Soluble CTLA-4 – A confounding factor in CTLA-4 based checkpoint immunotherapy in cancer

Immunology Letters
Cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) is a receptor that inhibits the activity of T cells. The CTLA-4 gene consists of four different exons that enable four different isoforms of CTLA-4 to be generated through alternative splicing. Although sCTLA-4 might impede the therapeutic effect of anti-CTLA-4 treatments, the role of sCTLA-4 in the ...
Parviz Azimnasab-sorkhabi   +4 more
openaire   +2 more sources

Pituitary Expression of CTLA-4 Mediates Hypophysitis Secondary to Administration of CTLA-4 Blocking Antibody

Science Translational Medicine, 2014
CTLA-4 blocking antibody induces secondary hypophysitis by binding to CTLA-4 antigen and initiating a type II hypersensitivity reaction.
Shintaro, Iwama   +5 more
openaire   +2 more sources

CTLA‐4 gene polymorphisms and natural soluble CTLA‐4 protein in psoriasis vulgaris

International Journal of Immunogenetics, 2006
SummaryCTLA‐4 molecule is an important inhibitor of T‐lymphocyte activation. Several single nucleotide polymorphisms (SNPs) in the CTLA‐4 gene were found, and their associations with many human diseases were described. So far, however, such studies have not been performed in psoriasis vulgaris in Caucasoids.
W, Luszczek   +9 more
openaire   +2 more sources

CTLA-4: Acting at the Synapse

Molecular Interventions, 2002
Shunsuke, Chikuma, Jeffrey A, Bluestone
openaire   +2 more sources

Home - About - Disclaimer - Privacy